Francisco Manuel Vega Moreno-rekin lankidetzan egindako argitalpenak (6)

2008

  1. The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

    Archives of Biochemistry and Biophysics, Vol. 465, Núm. 1, pp. 219-226

2006

  1. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines

    FEBS Journal, Vol. 273, Núm. 11, pp. 2487-2504

  2. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma

    Molecular Cancer Research, Vol. 4, Núm. 3, pp. 177-185

  3. p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop

    Molecular and Cellular Biology, Vol. 26, Núm. 13, pp. 4782-4793

2004

  1. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism

    Virology, Vol. 328, Núm. 2, pp. 254-265